Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
8329.HK Stock Price Chart
Explore Shenzhen Neptunus Interlong Bio-technique Company Limited interactive price chart. Choose custom timeframes to analyze 8329.HK price movements and trends.
8329.HK Company Profile
Discover essential business fundamentals and corporate details for Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
12 Sept 2005
Employees
1.49K
Website
https://www.interlong.comCEO
Feng Zhang
Description
Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology products. In addition, the company manufactures herbal medicines and generic drugs products, as well as medical devices. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
8329.HK Financial Timeline
Browse a chronological timeline of Shenzhen Neptunus Interlong Bio-technique Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 Aug 2025
Earnings released on 26 May 2025
Dividend declared on 15 May 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 6 Jun 2025.
Earnings released on 25 Mar 2025
EPS came in at -$0.00 , while revenue for the quarter reached $264.46M .
Earnings released on 29 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $275.09M .
Earnings released on 23 Aug 2024
EPS came in at $0.01 , while revenue for the quarter reached $283.70M .
Earnings released on 27 May 2024
EPS came in at $0.01 , while revenue for the quarter reached $303.29M .
Earnings released on 27 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $267.49M .
Earnings released on 7 Nov 2023
EPS came in at $0.01 , while revenue for the quarter reached $287.07M .
Earnings released on 11 Aug 2023
EPS came in at $0.01 , while revenue for the quarter reached $276.64M .
Earnings released on 8 May 2023
EPS came in at $0.01 , while revenue for the quarter reached $342.12M .
Earnings released on 23 Mar 2023
EPS came in at $0.01 , while revenue for the quarter reached $275.21M .
Earnings released on 31 Dec 2022
EPS came in at $0.02 , while revenue for the quarter reached $338.59M .
Earnings released on 30 Jun 2022
EPS came in at $0.00 , while revenue for the quarter reached $261.26M .
Earnings released on 31 Mar 2022
EPS came in at $0.01 , while revenue for the quarter reached $265.83M .
Earnings released on 31 Dec 2021
EPS came in at $0.01 , while revenue for the quarter reached $296.33M .
Earnings released on 30 Sept 2021
EPS came in at $0.00 , while revenue for the quarter reached $247.96M .
Earnings released on 30 Jun 2021
EPS came in at $0.00 , while revenue for the quarter reached $206.40M .
Earnings released on 31 Mar 2021
EPS came in at $0.01 , while revenue for the quarter reached $259.67M .
Earnings released on 31 Dec 2020
EPS came in at $0.01 , while revenue for the quarter reached $322.66M .
Earnings released on 30 Sept 2020
EPS came in at $0.01 , while revenue for the quarter reached $342.23M .
8329.HK Stock Performance
Access detailed 8329.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.